XYLOCOR THERAPEUTICS, INC.

Profile

Company Names

XYLOCOR THERAPEUTICS, INC.

Addresses

39 ADDISON LANE, MALVERN, PA 19355

76 LONGVIEW LANE, NEWTOWN SQUARE, PA 19073

Phone Numbers

610-457-9233

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$21,410,000.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2021-01-14 
$4,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
5
2018-10-04 
$16,800,000.00 
$16,800,000.00 
$0.00 
Equity 
4
2018-07-16 
$200,000.00 
$200,000.00 
$0.00 
Debt 
3
2018-03-05 
$60,000.00 
$150,000.00 
$90,000.00 
Debt 
2
2017-11-27 
$100,000.00 
$100,000.00 
$0.00 
Debt 
1
2016-11-10 
$250,000.00 
$1,000,000.00 
$750,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FOUAD 
 
AZZAM, PH.D. 
DIRECTOR
XYLOCOR THERAPEUTICS, INC.
GLENN 
 
BATCHELDER 
DIRECTOR
CIVITAS THERAPEUTICS, INC.   |  XYLOCOR THERAPEUTICS, INC.   |  SYNSPIRA, LLC   |  RESET THERAPEUTICS, INC.   |  KANTUM DIAGNOSTICS, INC.   |  SYNCHRONICITY PHARMA, INC.   |  KANTUM PHARMA, INC.
JAMES 
 
COHEN 
DIRECTOR
FITZ GATE VENTURES, L.P.   |  XYLOCOR THERAPEUTICS, INC.   |  HUDSON CAPITAL GEORGETOWN, LLC   |  HUDSON CAPITAL RICHMOND, LLC   |  HUDSON CAPITAL CHARLOTTE, LLC   |  HUDSON CAPITAL CHATTANOOGA, LLC
ALBERT 
 
GIANCHETTI 
EXECUTIVE OFFICER, DIRECTOR
XYLOCOR THERAPEUTICS, INC.
AIDAN 
 
KING 
DIRECTOR
PALYON MEDICAL CORP   |  CIVITAS THERAPEUTICS, INC.   |  CHRONO THERAPEUTICS INC.   |  VELICEPT THERAPEUTICS, INC.   |  XYLOCOR THERAPEUTICS, INC.
MICHAEL 
F. 
POWELL, PH.D. 
DIRECTOR
XYLOCOR THERAPEUTICS, INC.
TODD 
 
ROSENGART 
DIRECTOR
XYLOCOR THERAPEUTICS, INC.
TODD 
K. 
ROSENGART, M.D. 
DIRECTOR
XYLOCOR THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-01-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-14 
2018-10-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-04 
2018-07-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-07-16 
2018-03-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-03-05 
2017-12-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-11-27 
2016-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-11-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#